The Cracking Cancer Podcast
The Cracking Cancer Podcast
Podcast Description
Welcome to Cracking Cancer, a podcast dedicated to breaking down the knowledge and cultural barriers between patients and healthcare providers. Our mission is to empower listeners with clear, accessible insights into cancer care and treatment options. Through expert interviews, patient stories, and Q&A, we aim to create a more informed and supportive cancer community. Join us as we crack the code to better communication, knowledge, and collaboration in the fight against cancer.
Podcast Insights
Content Themes
Topics explored in Cracking Cancer include cancer biology, treatment options, emotional aspects of cancer, and the importance of community support. For instance, episodes discuss the significance of molecular profiling and how lifestyle factors can impact cancer, alongside personal narratives like Samantha Murrell's journey with stage four lung cancer.
Join Dr. Kyle Concannon, an MD Anderson–trained cancer doctor and scientist, together with the patient community, as we break down the knowledge and cultural barriers between cancer patients and cancer providers. Cracking Cancer empowers listeners with clear, accessible insights into cancer care, treatment options, and the complex world of cancer. Here, academic experts (providers) and experiential experts (patients) come together to discuss critical topics and build a more informed, supportive cancer community. Join us as we crack the code to better communication, knowledge, and collaboration in the fight against cancer. This podcast is intended for informational purposes only. It does not constitute medical advice and should not be relied upon as such. The views expressed are those of the participants and not of their affiliated organizations.
Deconstructing Fenbendazole: Scaffolding, Solvents, and the “Joe Tippens” Protocol
In this highly requested follow-up to their Ivermectin discussion, host Dr. Kyle Concannon, patient advocate Samantha Murrell, and science communicator Rob Swanda, PhD, touch the hot stove of alternative oncology once again. This time, they dive deep into Fenbendazole (commonly called “Fenben”), an antiparasitic veterinary drug that has exploded in popularity across cancer forums due to the viral “Joe Tippens Protocol.” Samantha opens up about her personal choice to take Fenbendazole secretly for eight months alongside conventional chemotherapy, providing an unfiltered look at the immense “what if” pressure patients face behind closed doors.
The conversation shifts to rigorous biochemical scrutiny as Dr. Kyle and Rob break down what the drug actually does inside a petri dish and a living organism. They expose the fascinating irony of alternative health branding: while Fenbendazole is frequently marketed online as a “natural, holistic alternative to harsh toxins,” it is completely synthetic. Conversely, the very chemotherapies it seeks to replace are the ones derived directly from nature. Moving step-by-step through peer-reviewed data, they analyze how this compound disrupts cellular architecture, why its therapeutic thresholds carry hidden toxicities, and how missing variables in animal models can obscure the difference between a true anti-tumor signal and a general cellular poison.
Key Takeaways:
- The Microtubule Mechanism (Chemo in Disguise)
- The P53 Gene Context
- The “Healthy Tissue” Toxicity Flaw
- Flawed Mouse Models & Missing Data
- Association vs. Causation
Want to get more involved with cancer research and support the podcast? Visit the link below: ⬇️ (All proceeds go strictly towards furthering cancer research and supporting this podcast)
For more information on Fenbendazole, check out Rob’s info-packed video below!
https://youtu.be/DDVko6G84wo
Want to see the data yourself? Check out the actual papers below:
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
https://pmc.ncbi.nlm.nih.gov/articles/PMC6085345/
Fenbendazole Exhibits Differential Anticancer Effects In Vitro and In Vivo in Models of Mouse Lymphoma
https://www.mdpi.com/1467-3045/45/11/560
Chapters:
(00:00) Why Fenbendazole Now
(01:38) Samantha Tries Fenben
(02:09) Joe Tippens Protocol Buzz
(04:04) How She Took It
(06:14) Social Pressure and Disclosure
(08:23) What Fenbendazole Is
(11:17) Microtubules and Cancer Logic
(13:29) Natural Versus Synthetic Debate
(17:25) Preclinical Evidence Deep Dive
(19:31) Mouse Study Caveats
(25:57) Safety Unknowns and Next Steps
(30:39) Paper Rigor Check
(31:42) Dose Response Reality
(33:15) P53 Dependency Explained
(38:25) Healthy Cell Toxicity
(40:32) Missing Controls Bias
(42:28) Second Study Lymphoma
(44:42) Why Immune Free Mice
(49:30) How Strong Is Evidence
(54:38) Anecdotes Versus Causation
(57:00) Mechanism Gaps Takeaways
(59:33) Final Verdict Sign Off
To find out more about supporting the show and research endeavors, please go to the following website: www.crackingcancer.org
Attributions
The music track – Progression Pulse – is provided by Denys Brodovskyi through the Attribution 4.0 International License
X: (1) Cracking Cancer Podcast (@Cracking_Cancer) / X
IG: Cracking Cancer (@crackingcancerpodcast) • Instagram photos and videos
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.